Theranostics Market Growth, Size, Segment & Forecast to 2034
Global Theranostics Market Growth, Size, Trends Analysis - By Product, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Jun-2025 | Report ID: MEDE2540 | Pages: 1 - 259 | Formats*: |
| Category : Medical Devices | |||
Theranostics Market Introduction and Overview
According to SPER Market Research, the Global Theranostics Market is estimated to reach USD 9.15 billion by 2034 with a CAGR of 13.85%.
The report includes an in-depth analysis of the Global Theranostics Market, including market size and trends, product mix, Applications, and supplier analysis.
Theranostics industry is predicted to be valued USD 2.5 billion in 2024, with a CAGR of 13.85% from 2025 to 2034.
One major factor propelling the market is the rising incidence of specific illnesses like cancer, heart disease, and autoimmune disorders. Innovative theranostic approaches that combine diagnostics and therapies are therefore becoming more and more necessary in order to optimise patient care, customise treatment plans, and enhance outcomes for those afflicted by these illnesses.
By Product Insights
The theranostics industry is classified into four main product categories: diagnostic imaging, radiopharmaceuticals, IVD/biomarkers screening, and software and services. Diagnostic imaging is the largest segment, expected to lead the market in 2024. Techniques like MRI, PET, and CT scans enable early disease detection, improving treatment outcomes and survival rates by providing detailed information on tumors or abnormalities. These imaging methods also help monitor therapy responses, which is essential for adjusting treatments as needed.
By Application Insights
The theranostics market is divided into applications such as prostate cancer, bone metastasis, neuroendocrine tumors, lymphoma, cardiovascular diseases, and others. Prostate cancer is projected to have the largest market share by 2034. Early detection of prostate cancer is facilitated by diagnostic imaging techniques like multiparametric magnetic resonance imaging (mpMRI) and positron emission tomography (PET) scans, even with low prostate-specific antigen (PSA) levels. These techniques allow for precise localization of cancer lesions, which helps in tailoring treatment plans based on the severity of the disease, thus enhancing patient outcomes.
By End User Insights
The market is also categorized by end-users, including hospitals, diagnostic centers, and specialty clinics, with hospitals generating the highest revenue in 2024. Hospitals offer comprehensive medical services and have advanced diagnostic imaging equipment crucial for theranostic procedures. They utilize multidisciplinary teams to create personalized treatment plans for patients with complex diseases, further driving market growth.
Regional Insights
In 2024, North America led the theranostics market, with expected significant growth. The region's advanced technology supports innovative theranostics, integrating modern diagnostics and therapeutics to tackle medical issues effectively. North America's developed healthcare system, featuring advanced facilities and a strong regulatory framework, facilitates the integration of these services and supports market expansion.
Market Competitive Landscape
There are a number of large multinational companies as well as small and mid-sized businesses that compete in the competitive theranostics sector. One important market approach is the creation and introduction of innovative, cutting-edge devices based on various technologies. Bayer AG, Beckman Coulter, Inc, Cardinal Health, Inc, Canon Medical Systems Corporation, Curium, F. Hoffmann La Roche Ltd, and GE HealthCare Technologies Inc are a few of the top companies in the sector.
Recent Developments:
GE Healthcare and the Mayo Clinic announced a strategic agreement in September 2023 to focus on medical imaging and theranostics research and product development. This relationship benefited both organisations by combining Mayo Clinic's clinical experience with GE Healthcare's technological capabilities to foster innovation in medical imaging and theranostics.
Bayer and the Broad Institute of MIT and Harvard expanded their research collaboration in November 2023, with a focus on cancer target identification and new oncology medicines. Bayer benefited from this relationship since it allowed them to leverage the Broad Institute's knowledge and advance its oncology drug pipeline.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Application, By End-User |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Bayer AG, Beckman Coulter, Inc, Cardinal Health, Inc, Canon Medical Systems Corporation, Curium, F. Hoffmann La Roche Ltd, GE HealthCare Technologies Inc, Koninklijke Philips N.V, Lantheus Holdings, Inc, Siemens Healthnieers AG, Thermo Fisher Scientific Inc. |
Key Topics Covered in the Report
- Global Theranostics Market Size (FY’2021-FY’2034)
- Overview of Global Theranostics Market
- Segmentation of Global Theranostics Market By Product (Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software, Services)
- Segmentation of Global Theranostics Market By Application (Prostate Cancer, Bone Metastasis, Neuroendocrine Tumors, Lymphoma, Cardiovascular diseases)
- Segmentation of Global Theranostics Market By End User (Hospitals, Diagnostics centers, Specialty clinics, Other end-users)
- Statistical Snap of Global Theranostics Market
- Expansion Analysis of Global Theranostics Market
- Problems and Obstacles in Global Theranostics Market
- Competitive Landscape in the Global Theranostics Market
- Details on Current Investment in Global Theranostics Market
- Competitive Analysis of Global Theranostics Market
- Prominent Players in the Global Theranostics Market
- SWOT Analysis of Global Theranostics Market
- Global Theranostics Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTER’s Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Theranostics Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Theranostics Market
7.Global Theranostics Market, By Product (USD Million) 2021-2034
7.1.Diagnostic imaging7.1.1.MRI7.1.2.PET imaging7.1.3.Nuclear imaging7.1.4.CT scan7.1.5.Molecular imaging7.1.6.Other diagnostic imaging7.2.Radiopharmaceuticals7.2.1.Lutetium-1777.2.2.Samarium-1537.2.3.Radium-2237.2.4.Iodine-1317.2.5.Yttrium-907.2.6.Gallium-687.2.7.Fluorine-187.2.8.Other radiopharmaceuticals7.3.IVD/Biomarker screening7.3.1.Polymerase chain reaction (PCR)7.3.2.Next-generation sequencing (NGS)7.3.3.Fluorescence in-situ hybridization (FISH)7.4.Software and services
8.Global Theranostics Market, By Application (USD Million) 2021-2034
8.1.Prostate cancer8.2.Bone metastasis8.3.Neuroendocrine tumors8.4.Lymphoma8.5.Cardiovascular diseases8.6.Other applications
9.Global Theranostics Market, By End-User (USD Million) 2021-2034
9.1.Hospitals9.2.Diagnostics centers9.3.Specialty clinics9.4.Other end-users
10.Global Theranostics Market, (USD Million) 2021-2034
10.1.Global Theranostics Market Size and Market Share
11.Global Theranostics Market, By Region, (USD Million) 2021-2034
11.1.Asia-Pacific11.1.1.Australia11.1.2.China11.1.3.India11.1.4.Japan11.1.5.South Korea11.1.6.Rest of Asia-Pacific11.2.Europe11.2.1.France11.2.2.Germany11.2.3.Italy11.2.4.Spain11.2.5.United Kingdom11.2.6.Rest of Europe11.3.Middle East and Africa11.3.1.Kingdom of Saudi Arabia11.3.2.United Arab Emirates11.3.3.Qatar11.3.4.South Africa11.3.5.Egypt11.3.6.Morocco11.3.7.Nigeria11.3.8.Rest of Middle-East and Africa11.4.North America11.4.1.Canada11.4.2.Mexico11.4.3.United States11.5.Latin America11.5.1.Argentina11.5.2.Brazil11.5.3.Rest of Latin America
12.Company Profile
12.1.Bayer AG12.1.1.Company details12.1.2.Financial outlook12.1.3.Product summary12.1.4.Recent developments12.2.Beckman Coulter, Inc12.2.1.Company details12.2.2.Financial outlook12.2.3.Product summary12.2.4.Recent developments12.3.Cardinal Health, Inc12.3.1.Company details12.3.2.Financial outlook12.3.3.Product summary12.3.4.Recent developments12.4.Canon Medical Systems Corporation12.4.1.Company details12.4.2.Financial outlook12.4.3.Product summary12.4.4.Recent developments12.5.Curium12.5.1.Company details12.5.2.Financial outlook12.5.3.Product summary12.5.4.Recent developments12.6.F. Hoffmann La Roche Ltd12.6.1.Company details12.6.2.Financial outlook12.6.3.Product summary12.6.4.Recent developments12.7.GE HealthCare Technologies Inc12.7.1.Company details12.7.2.Financial outlook12.7.3.Product summary12.7.4.Recent developments12.8.Koninklijke Philips N.V12.8.1.Company details12.8.2.Financial outlook12.8.3.Product summary12.8.4.Recent developments12.9.Siemens Healthnieers AG12.9.1.Company details12.9.2.Financial outlook12.9.3.Product summary12.9.4.Recent developments12.10.Thermo Fisher Scientific Inc12.10.1.Company details12.10.2.Financial outlook12.10.3.Product summary12.10.4.Recent developments12.11.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
"
The report includes an in-depth analysis of the Global Theranostics Market, including market size and trends, product mix, Applications, and supplier analysis. "
the Theranostics Market is projected to reach USD 9.15 by 2034, growing at a CAGR of 13.85% during the forecast period.
the Theranostics Market size from 2025. The Market is expected to reach USD 9.15 by 2034, at a CAGR of 13.85% during the forecast period.
the Theranostics Market CAGR of 13.85% during the forecast period.
You can get the sample pages by clicking the link - Click Here
the Theranostics Market size is USD 9.15 from 2025 to 2034.
the Theranostics Market covered By Product, By Application, By End-User
The North America is anticipated to have the highest Market share in the Theranostics Market .
"
Bayer AG, Beckman Coulter, Inc, Cardinal Health, Inc, Canon Medical Systems Corporation, Curium, F. Hoffmann La Roche Ltd, GE HealthCare Technologies Inc, Koninklijke Philips N.V, Lantheus Holdings, Inc, Siemens Healthnieers AG, Thermo Fisher Scientific Inc. "
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
